The US Congress has passed the Lindsey Graham Sanctioning Russia and Iran Act of 2026, empowering President Donald Trump to impose 100% tariffs on top five importers of Russian energy, including China and India.
The Trump administration’s decision to impose 200% tariffs on generic drugs is expected to have direct implications for India, which exported pharmaceuticals worth over $9.7 billion to the US in 2025.
Earlier, on 3rd June, Washington proposed imposing a 12.5% tariff on imports from 54 countries, including India, accusing them of failing to ban goods linked to forced labour.
While the US Supreme Court struck down Trump’s reciprocal tariffs, and an additional 25% tariff on India for buying Russian oil was withdrawn earlier this year,...
In the report titled “Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced with Forced Labor”, the USTR detailed the findings of the investigation launched into trading partners under Section 301 (b)(1) of the Trade Act of 1974.
Trump insisted that the India-US trade deal remains on track. “I think my relationship with India is fantastic, and we're doing trade with India,” he said.